SCHEDULE 13D/A: Coliseum Capital Entities Reduce Stake in Universal Technical Institute, Selling Over 700,000 Shares
Beneficial Ownership Amendment
Coliseum Capital Management, LLC and its affiliates have reduced their beneficial ownership in Universal Technical Institute, Inc. to 11.3% following a block sale of over 700,000 shares.
Summary
- Coliseum Capital Management, LLC, along with its affiliates Coliseum Capital, LLC and Coliseum Capital Partners, L.P., and principals Adam Gray and Christopher Shackelton, filed an Amendment No. 9 to their Schedule 13D.
- The filing reports a reduction in their beneficial ownership of Universal Technical Institute, Inc. (UTI) common stock.
- As of February 10, 2025, Coliseum Capital Management, LLC, Adam Gray, and Christopher Shackelton collectively beneficially own 6,145,755 shares, representing 11.3% of UTI's outstanding common stock.
- Coliseum Capital, LLC and Coliseum Capital Partners, L.P. beneficially own 5,094,988 shares, representing 9.4% of UTI's outstanding common stock.
- On February 10, 2025, Coliseum Capital Partners, L.P. executed a block sale of 584,364 shares at $28.20 per share.
- Additionally, a separate account investment advisory client of Coliseum Capital Management, LLC executed a block sale of 120,517 shares at $28.20 per share on the same date.
- The total number of shares sold by the reporting persons and their client was 704,881 shares.
- The percentages of ownership are calculated based on 54,371,711 shares of Common Stock outstanding as of February 1, 2025, as reported in UTI's Quarterly Report on Form 10-Q filed on February 6, 2025.
Sentiment
Score: 3
Explanation: The sentiment is moderately negative due to a significant institutional investor reducing its stake in the company through a block sale, which can be interpreted as a lack of conviction or a strategic exit.
Negatives
- A significant block sale by a major institutional investor (Coliseum Capital entities) could be perceived negatively by the market, potentially signaling a lack of confidence or a strategic portfolio rebalancing away from the issuer.
- The reduction in stake by Coliseum Capital Partners, L.P. and a separate account client indicates a decrease in their conviction or a move to realize gains.
Risks
- The sale of a substantial block of shares by a significant investor could put downward pressure on the stock price of Universal Technical Institute, Inc.
- A reduction in ownership by a major shareholder might be interpreted by other investors as a negative signal regarding the company's future prospects or valuation.
Future Outlook
The document does not contain any forward-looking statements or guidance regarding the issuer's future performance or strategic direction. It solely reports changes in beneficial ownership.
Industry Context
This filing is a routine disclosure of a change in beneficial ownership by a significant institutional investor. It does not provide broader industry context or trends, but a reduction in stake by a major holder could be a signal for the market within the specialized post-secondary education sector where Universal Technical Institute operates.
Stakeholder Impact
- Shareholders: The reduction in stake by a major investor could lead to negative market sentiment and potential downward pressure on the stock price, impacting shareholder value.
- Investment Professionals: Analysts and investors will likely scrutinize this sale for insights into Coliseum Capital's view on UTI's future prospects, potentially influencing their own investment decisions.
Key Dates
| Date | Description |
|---|---|
| 2016-03-21 | Initial Schedule 13D filing date by reporting persons. |
| 2016-06-28 | Amendment No. 1 to Initial 13D filed. |
| 2019-12-19 | Amendment No. 2 to Initial 13D filed. |
| 2020-09-16 | Amendment No. 3 to Initial 13D filed. |
| 2022-12-29 | Amendment No. 4 to Initial 13D filed. |
| 2023-06-26 | Amendment No. 5 to Initial 13D filed. |
| 2023-12-19 | Amendment No. 6 to Initial 13D filed. |
| 2024-02-16 | Amendment No. 7 to Initial 13D filed. |
| 2024-12-03 | Amendment No. 8 to Initial 13D filed. |
| 2025-02-01 | Date as of which 54,371,711 shares of Common Stock were outstanding, as reported in the Issuer's Form 10-Q. |
| 2025-02-06 | Date the Issuer's Quarterly Report on Form 10-Q was filed with the SEC. |
| 2025-02-10 | Date of the block sales of Common Stock by Coliseum Capital Partners, L.P. and a Separate Account. |
| 2025-02-11 | Date of filing of this Amendment No. 9 to Schedule 13D. |
Keywords
Universal Technical Institute, UTI, Coliseum Capital Management, Coliseum Capital Partners, Schedule 13D, SEC filing, beneficial ownership, stock sale, institutional investor, common stock, equity stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.